Diabetic Neuropathies

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Mesa, Arizona, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Irvine, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Long Beach, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Los Angeles, California, United States

• Diablo Clinical Research, Inc. — Walnut Creek, California, United States
• Clinical Research of West Florida, Inc. — Clearwater, Florida, United States
• Translational Pain Research Group, Brigham & Women's Hospital — Boston, Massachusetts, United States
• American Center for Clinical Trials — Southfield, Michigan, United States

Not specified

• Ciro Ramos Estebanez — Chicago, Illinois, United States
• University Hospitals Cleveland Medical Center/ Dahms Clinical Research Unit — Cleveland, Ohio, United States

• The University of Faisalabad — Faisalābad, Punjab Province, Pakistan

• Seoul National University Hospital — Seoul, South Korea

• University of Iowa — Iowa City, Iowa, United States
• Oregon Health Science University — Portland, Oregon, United States

• Imperial College London — London, United Kingdom